Literature DB >> 11231644

Phosphorylcholine-coated stents in porcine coronary arteries: in vivo assessment of biocompatibility.

N Malik1, J Gunn, L Shepherd, D C Crossman, D C Cumberland, C M Holt.   

Abstract

AIMS: To examine the angiographic (quantitative coronary angiography), morphometric, light microscopic (LM) (i.e., histology and immunohistochemical staining) and electron microscopic (EM) findings after implantation of phosphorylcholine (PC)-coated compared to uncoated stents in porcine coronary arteries.
METHODS: Forty (25 PC-coated, 15 uncoated) divYsio stents were implanted into the coronary arteries of 20 pigs. Quantitative coronary angiography (QCA) was performed pre-stent and post-implantation in fifteen pigs, at 28 days. Two pigs were killed at 5 days (LM and scanning EM), one pig at 14 days (scanning EM) and 17 pigs at 28 days (LM, scanning EM, transmission EM). At 28 days, thirty-two of 34 stented segments excised were formalin-fixed, of which 30 were embedded in resin and sectioned for morphometry and LM. Remaining stents were examined by TEM and SEM.
RESULTS: No angiographically occlusive thrombosis occurred in any of the stents. LM at 5 days showed endothelialization of PC-coated and uncoated stents, which was also confirmed by scanning EM at 14 days. At 28 days, QCA and morphometry showed no significant differences between PC-coated and uncoated stents. A few inflammatory cells were seen in both stent types at 5 days but there was no inflammatory or additional tissue reaction to PC-coated compared to uncoated stents at 28 days.
CONCLUSIONS: The divYsio stents, with or without PC coating, performed equally well in terms of acute patency, 28-day QCA and morphometry. The PC coating allows a stent to endothelialize normally and is not associated with specific histological changes. The PC coating on the divYsio stent appears biocompatible.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231644

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  10 in total

1.  Methotrexate eluting stents: to modify or cure?

Authors:  A C Morton; J Gunn
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

2.  Response of very small (2 mm) porcine coronary arteries to balloon angioplasty and stent implantation.

Authors:  A C Morton; N D Arnold; D C Crossman; J Gunn
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

Review 3.  The future of drug eluting stents.

Authors:  R R Anis; K R Karsch
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

Review 4.  Coronary stents: in these days of climate change should all stents wear coats?

Authors:  R Lowe; I B A Menown; G Nogareda; I M Penn
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

Review 5.  Coronary artery stents: identification and evaluation.

Authors:  J Butany; K Carmichael; S W Leong; M J Collins
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

Review 6.  Nanotechnology in interventional cardiology.

Authors:  Tillmann Cyrus; Samuel A Wickline; Gregory M Lanza
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-07-11

7.  Coronary artery stretch versus deep injury in the development of in-stent neointima.

Authors:  J Gunn; N Arnold; K H Chan; L Shepherd; D C Cumberland; D C Crossman
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

8.  Vascular Response on a Novel Fibrin-Based Coated Flow Diverter.

Authors:  Giorgio Cattaneo; Christoph Brochhausen; Ruben Mühl-Benninghaus; Frederik Fries; Mara Kießling; Toshiki Tomori; Stefanie Krajewski; Andreas Simgen; Sabina Bauer; Natascha Hey; Eduard Brynda; Johanka Taborska; Tomáš Riedel; Wolfgang Reith
Journal:  Cardiovasc Intervent Radiol       Date:  2021-12-16       Impact factor: 2.740

9.  Advances in drug eluting stents - focus on the Endeavor(®) zotarolimus stent.

Authors:  Jonathan Bridges; Donald Cutlip
Journal:  Med Devices (Auckl)       Date:  2008-12-07

10.  Safety and Efficacy of the Endeavor Resolute® Stent in Patients with Multivessel Disease: The HEART (Honam EndeAvor ResoluTe) Prospective, Multicenter Trial.

Authors:  Doo Sun Sim; Myung Ho Jeong; Young Joon Hong; Ju Han Kim; Youngkeun Ahn; Keun Ho Park; Sun Ho Hwang; Dong Goo Kang; Seung Uk Lee; Joon Woo Kim; Jong Pil Park; Jay Young Rhew; Sang Rok Lee; Jei Keon Chae; Kyeong Ho Yun; Seok Kyu Oh; Won You Kang; Su Hyun Kim; Jang Hyun Cho
Journal:  Chonnam Med J       Date:  2018-01-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.